BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 34368858)

  • 1. Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review).
    Wang L; Qian J; Yang Y; Gu C
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation in carcinogenesis.
    Bettermann K; Benesch M; Weis S; Haybaeck J
    Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SUMO Pathway in Hematomalignancies and Their Response to Therapies.
    Boulanger M; Paolillo R; Piechaczyk M; Bossis G
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO pathway components as possible cancer biomarkers.
    Mattoscio D; Chiocca S
    Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SUMO Signaling to Wrestle Cancer.
    Kroonen JS; Vertegaal ACO
    Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Cellular Processes by SUMO: Understudied Topics.
    Enserink JM
    Adv Exp Med Biol; 2017; 963():89-97. PubMed ID: 28197907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.
    Gareau JR; Lima CD
    Nat Rev Mol Cell Biol; 2010 Dec; 11(12):861-71. PubMed ID: 21102611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The important roles of protein SUMOylation in the occurrence and development of leukemia and clinical implications.
    Zhao B; Zhang Z; Chen X; Shen Y; Qin Y; Yang X; Xing Z; Zhang S; Long X; Zhang Y; An S; Wu H; Qi Y
    J Cell Physiol; 2021 May; 236(5):3466-3480. PubMed ID: 33151565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the sumoylation system in gene expression.
    Liu B; Shuai K
    Curr Opin Cell Biol; 2008 Jun; 20(3):288-93. PubMed ID: 18468876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling pathways and the regulation of SUMO modification.
    Guo B; Yang SH; Witty J; Sharrocks AD
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1414-8. PubMed ID: 18031234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Molecular Interface Between the SUMO and Ubiquitin Systems.
    Staudinger JL
    Adv Exp Med Biol; 2017; 963():99-110. PubMed ID: 28197908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of SUMO in Metabolic Regulation.
    Kamynina E; Stover PJ
    Adv Exp Med Biol; 2017; 963():143-168. PubMed ID: 28197911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
    Reiter K; Mukhopadhyay D; Zhang H; Boucher LE; Kumar N; Bosch J; Matunis MJ
    J Biol Chem; 2013 Sep; 288(39):27724-36. PubMed ID: 23943616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
    He X; Riceberg J; Pulukuri SM; Grossman S; Shinde V; Shah P; Brownell JE; Dick L; Newcomb J; Bence N
    PLoS One; 2015; 10(4):e0123882. PubMed ID: 25860128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-dependent conjugation of endogenous BRCA1 protein with SUMO-2/3.
    Vialter A; Vincent A; Demidem A; Morvan D; Stepien G; Venezia ND; Rio PG
    Biochim Biophys Acta; 2011 Apr; 1810(4):432-8. PubMed ID: 21147198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.